Literature DB >> 3321006

Management of sickle cell disease.

M Brozović1, S Davies.   

Abstract

Mesh：

Year:  1987        PMID： 3321006      PMCID： PMC2428428          DOI： 10.1136/pgmj.63.742.605

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  10 in total

1.  Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.

Authors:  M H Gaston; J I Verter; G Woods; C Pegelow; J Kelleher; G Presbury; H Zarkowsky; E Vichinsky; R Iyer; J S Lobel
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

2.  Neonatal screening for sickle cell diseases in Camberwell: results and recommendations of a two year pilot study.

Authors:  M E Horn; M C Dick; B Frost; L R Davis; A J Bellingham; C E Stroud; J W Studd
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

Review 3.  Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (first of three parts).

Authors:  J Dean; A N Schechter
Journal:  N Engl J Med       Date:  1978-10-05       Impact factor: 91.245

4.  Acute chest syndrome in sickle-cell disease.

Authors:  S C Davies; P J Luce; A A Win; J F Riordan; M Brozovic
Journal:  Lancet       Date:  1984-01-07       Impact factor: 79.321

5.  Screening cord blood for sickle haemoglobinopathies in Brent.

Authors:  J Henthorn; E Anionwu; M Brozovic
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-25

6.  The natural history of stroke in sickle cell disease.

Authors:  D Powars; B Wilson; C Imbus; C Pegelow; J Allen
Journal:  Am J Med       Date:  1978-09       Impact factor: 4.965

7.  Early deaths in Jamaican children with sickle cell disease.

Authors:  D W Rogers; J M Clarke; L Cupidore; A M Ramlal; B R Sparke; G R Serjeant
Journal:  Br Med J       Date:  1978-06-10

8.  Priapism and impotence in homozygous sickle cell disease.

Authors:  A M Emond; R Holman; R J Hayes; G R Serjeant
Journal:  Arch Intern Med       Date:  1980-11

9.  Sickle cell disease in Britain.

Authors:  M Brozović; E Anionwu
Journal:  J Clin Pathol       Date:  1984-12       Impact factor: 3.411

10.  Hepatic sequestration in sickle cell anaemia.

Authors:  C S Hatton; C Bunch; D J Weatherall
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-09
  10 in total
  10 in total

1.  Services for sickle cell disease: unified approach needed.

Authors:  I M Franklin
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-27

Review 2.  Hydroxyurea (hydroxycarbamide) for sickle cell disease.

Authors:  Angela E Rankine-Mullings; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2022-09-01

3.  Bone marrow transplantation in sickle cell anaemia.

Authors:  C Vermylen; G Cornu; M Philippe; J Ninane; A Borja; D Latinne; A Ferrant; J L Michaux; G Sokal
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

4.  Creatine kinase activity in sickle cell disease.

Authors:  B J Hunt; P Korsah; S Eaton; M Brozovic
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

Review 5.  Piracetam for reducing the incidence of painful sickle cell disease crises.

Authors:  Amani Al Hajeri; Zbys Fedorowicz
Journal:  Cochrane Database Syst Rev       Date:  2016-02-12

Review 6.  Hydroxyurea (hydroxycarbamide) for sickle cell disease.

Authors:  Sarah J Nevitt; Ashley P Jones; Jo Howard
Journal:  Cochrane Database Syst Rev       Date:  2017-04-20

7.  Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease.

Authors:  Sudipta Pal; Ruchita Dixit; Soe Moe; Myron Anthony Godinho; Adinegara Bl Abas; Samir K Ballas; Shanker Ram; Uduman Ali M Yousuf
Journal:  Cochrane Database Syst Rev       Date:  2020-03-03

8.  Factors associated with hospital readmission in sickle cell disease.

Authors:  Monique Morgado Loureiro; Suely Rozenfeld; Marilia Sá Carvalho; Rodrigo Doyle Portugal
Journal:  BMC Blood Disord       Date:  2009-02-27

Review 9.  Hypertransfusion therapy in sickle cell disease in Nigeria.

Authors:  Ademola Samson Adewoyin; Jude Chike Obieche
Journal:  Adv Hematol       Date:  2014-08-07

10.  Endothelin type A receptors mediate pain in a mouse model of sickle cell disease.

Authors:  Brianna Marie Lutz; Shaogen Wu; Xiyao Gu; Fidelis E Atianjoh; Zhen Li; Brandon M Fox; David M Pollock; Yuan-Xiang Tao
Journal:  Haematologica       Date:  2018-03-15       Impact factor: 9.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.